Scn2a Foundation logo

Scn2a Foundation

Our mission is to accelerate targeted research and therapeutic development for those diagnosed with scn2a related disorders.

We don’t currently support donations to this nonprofit. To request we add support email us.

Our children cannot wait. Neither will we.

SCN2A disorders cause severe pediatric epilepsy, autism, and intellectual disability. There is no cure. No disease-modifying therapy. Just families watching their children seize, regress, and lose ground every day we delay.

The SCN2A Foundation was built to close that gap — with speed, science, and capital efficiency the traditional system doesn't allow.

We pursue three paths to a treatment, simultaneously:

  • Small molecules — oral therapies that can scale to every patient
  • Genetic medicines — ASOs and precision approaches that target SCN2A at its source
  • AI for families — the first domain-tuned AI in rare disease, putting clinical insight directly into caregivers' hands

Why we can deliver:

I founded this Foundation after my own son's diagnosis, bringing 20+ years building and scaling technology companies (Centric Digital, Mutual Mobile, Vaimo) and advising leading genomics organizations (Invitae, Exact Sciences, Probably Genetic, Citizen Health). I hold MIT certificates in Drug Development and AI in Pharma & Biotech, and was selected for the Milken Institute FasterCures LeadersLink 2026 cohort.

Our work has already contributed to a Praxis Precision Medicines IND filing, optimized the PRAX-562 Phase 2 trial design, and launched an active drug discovery collaboration with Unravel Biosciences.

Our team brings the credibility this work demands:

  • Shannon Curry, RN, Co-Founder — 20+ years across UPMC, Albert Einstein College of Medicine, and Westchester Medical Center
  • Ryan Quiel — Product leader at Gusto, former co-founder of Giving Assistant
  • Mathew Lawrence — Clinical research and healthcare analytics leader, Six Sigma certified
  • Dr. Jerry Vockley, MD, PhD — Chief of Medical Genetics at UPMC Children's Hospital of Pittsburgh; FDA Genetic Metabolic Disease Advisory Committee
  • Dr. Jerry Kartzinel, MD, FAAP — NYT bestselling author, 25+ years in pediatric integrative medicine
  • Val Prisecaru, MS, CN, LDN — Precision health and nutrigenomics expert

We operate lean. Pro bono counsel from Morrison & Foerster. Every dollar moves directly to the science and the families.

Your gift compresses the timeline between diagnosis and treatment. That's not rhetoric — it's what we do, every week, with the resources we're given.

Help us deliver. Donate today.

Dover, DE
scn2afoundation.org
A 501(c)(3) nonprofit, EIN 92-2444780

Become a supporter!

Donate or start a fundraiser